Translational Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-12-04 冬瓜不是瓜来自广东省

偏重的研究方向：肿瘤;Oncology
经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！

9 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-09-28 ms7000000967071545 来自浙江省

记录
2024-8-19 从cancer letters转投过来
2024-8-22 With editor
2024-9-27 Under Review
编辑那卡了好久，希望送审能顺利，拜托🙏！！！

28 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-12-17 ms1000000722283592 来自重庆

偏重的研究方向：肿瘤免疫
经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运

5 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-10-18 LBJ 来自海南省

转投过来的，目前两天了还是submitted to journal

16 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-12-12 ms6000000015699475 来自江苏省

请问大佬们一直不送审是不是有等着作者主动撤稿的意思？

3 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-11-22 ms1000000530523465 来自山东省

大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？

1 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-09-12 ms5000001558887674 来自江苏省

9.01 submit
9.02 with editor
9.12 还是 with editor，这啥情况啊能不能痛快点

22 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-09-10 ms3000000081429133 来自河南省

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：2024-7-31 submit
2024-8-9 under review
2024-8-22 under review
2024-9-5 一个审稿人完成审稿

25 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-11-26 ms1000000794282034

有大佬投过综述吗？在线请教经验

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2240741, encodeId=8de52240e419e, content=偏重的研究方向：肿瘤;Oncology 经验分享：干嘛呀，官网不是说这个流程很快嘛？为啥我都一个多月了还在with editor啊😦这也太慢了吧，着急毕业的别投，太坑了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56928216435, createdName=冬瓜不是瓜, createdTime=Wed Dec 04 09:16:09 CST 2024, time=2024-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2228225, encodeId=86f122282254a, content=记录 2024-8-19 从cancer letters转投过来 2024-8-22 With editor 2024-9-27 Under Review 编辑那卡了好久，希望送审能顺利，拜托🙏！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6098126586, createdName=ms7000000967071545, createdTime=Sat Sep 28 17:54:12 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2243086, encodeId=eb5d2243086d0, content=偏重的研究方向：肿瘤免疫 经验分享：2024.11.27提交，11.28就with editor，到现在过去马上三周了没变化……接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4a28539390, createdName=ms1000000722283592, createdTime=Tue Dec 17 11:10:35 CST 2024, time=2024-12-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231646, encodeId=89e72231646f6, content=转投过来的，目前两天了还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Fri Oct 18 23:30:00 CST 2024, time=2024-10-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2241962, encodeId=1f062241962e7, content=请问大佬们一直不送审是不是有等着作者主动撤稿的意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91eb9565806, createdName=ms6000000015699475, createdTime=Thu Dec 12 08:34:01 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2238505, encodeId=4148223850555, content=大佬们，想问一下，杂志的cover letter，必须使用官方信头，带有所在机构的标志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00508318813, createdName=ms1000000530523465, createdTime=Fri Nov 22 18:42:56 CST 2024, time=2024-11-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2225394, encodeId=10cb222539483, content=9.01 submit 9.02 with editor 9.12 还是 with editor，这啥情况啊能不能痛快点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=025b6459612, createdName=ms5000001558887674, createdTime=Thu Sep 12 14:34:51 CST 2024, time=2024-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225009, encodeId=a17b22250095a, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2024-7-31 submit 2024-8-9 under review 2024-8-22 under review 2024-9-5 一个审稿人完成审稿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ef6418566, createdName=ms3000000081429133, createdTime=Tue Sep 10 15:35:43 CST 2024, time=2024-09-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2239209, encodeId=132e22392098f, content=有大佬投过综述吗？在线请教经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4b99377849, createdName=ms1000000794282034, createdTime=Tue Nov 26 09:49:20 CST 2024, time=2024-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231694, encodeId=867622316946a, content=今天With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52655431690, createdName=LBJ, createdTime=Sat Oct 19 11:37:26 CST 2024, time=2024-10-19, status=1, ipAttribution=海南省)]

2024-10-19 LBJ 来自海南省

今天With Editor

14 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务